Riskpilot← Back to searchSign inGet full accessBRAND THERAPY AB
ABActiveOrg 5567751812Fryxellsgatan 4Business and other management consultancy activities · NACE 7020Est. 20091 employees
Revenue 2024
SEK 117K
-96% vs 2023
EBITDA margin
-149.6%
-108% vs 2023
Equity ratio
76.1%
Financial strength
Net profit 2024
SEK -17K
-101% vs 2023
| Revenue | SEK 117K | -96% |
| EBITDA | SEK -175K | -108% |
| Net profit | SEK -17K | -101% |
| Total assets | SEK 2,3M | -22% |
| Equity | SEK 1,7M | -11% |
| Employees | 1 | — |
Legal name
BRAND THERAPY AB
Org number
5567751812
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
5 januari 2009
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom varumärkesstrategi, marknadsföring, organisation och affärsutveckling samt därmed förenlig verksamhet. Importverksamhet inom mode.
Address
Fryxellsgatan 4
Phone
+46702677135
Email
peter.jannero@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 330 | 571 | 638 | 3 086 | 117 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 312 | 541 | 590 | 2 196 | −175 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 312 | 541 | 590 | 2 196 | −175 |
| Net financials | — | — | — | 15 | 49 |
| Profit before tax | 313 | 548 | 591 | 1 662 | −17 |
| Tax | −67 | −113 | −122 | −343 | −0 |
| Net profit | 246 | 435 | 469 | 1 319 | −17 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 503 | 798 | 1 154 | 2 912 | 2 276 |
| Equity | 345 | 539 | 821 | 1 952 | 1 731 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 152 | 259 | 334 | 410 | 105 |
| Total debt | 152 | 259 | 334 | 410 | 105 |
EBITDA margin
-149.6%
This company
15.8%
Market median
-1047% vs market
20202024
Equity ratio
76.1%
This company
38.2%
Market median
+99% vs market
20202024
Return on equity
-1.0%
This company
18.4%
Market median
-105% vs market
20202024
Net profit margin
-14.5%
This company
8.1%
Market median
-279% vs market
20202024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PL Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
AM External Signatory | External Signatory | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BRAND THERAPY AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anette Monika Jannerö | External Signatory | 0 companies |
| Peter Lennart Magnus Jannerö | Chief Executive Officer | 0 companies |
| Monika Olu Eliasson | Deputy Board Member | 0 companies |